Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...

Age-related macular degeneration blinds more older adults in Western countries than any other retinal disease. Neovascular AMD, while less common than its dry counterpart, causes nearly all cases of ...

Share on Pinterest GLP-1 drugs like Ozempic could lead to a higher risk of wet age-related macular degeneration in people with type 2 diabetes. Westend61/Getty Images GLP-1 drugs are associated with a ...

Pachydrusen-associated AMD may progress slower than typical AMD. Age and macular pigment changes increase the risk of complications. Current AMD risk models may not apply to eyes with pachydrusen. AMD ...

Older diabetic patients on two GLP-1 drugs showed an increased risk of neovascular age-related macular degeneration in an observational cohort study. The absolute risk was small, however, reaching 0.2 ...

A new study published in Nature Communications reveals the specific genetic factors linked to the presence of reticular pseudodrusen—deposits that drive vision loss and are found on the retina of up ...

Ask a clinical question and tap into Healio AI's knowledge base. Assessment of visual function by testing for visual acuity, dark adaptation, contrast sensitivity and evaluation of retinal sensitivity ...

Please provide your email address to receive an email when new articles are posted on . GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic ...

Preliminary studies suggest GLP-1s may offer long-term vision protection for people without diabetes, but researchers caution more research is still needed. During a 10-year study, people without ...